Sep / 2025

OncoDaily IO OncoDaily GI Hemostasis Today

03/04/2024

Apr 3, 2024 7:25 pm

Apr 3, 2024 7:19 pm

Apr 3, 2024 4:25 pm

Apr 3, 2024 4:21 pm

Apr 3, 2024 3:47 pm

Apr 3, 2024 3:42 pm

Apr 3, 2024 3:36 pm

Apr 3, 2024 3:25 pm

Apr 3, 2024 3:19 pm

Apr 3, 2024 3:13 pm

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

03/04/2024

Bishoy Faltas: Thrilled to take on this new role as Chief Research Officer of the Englander Institute for Precision Medicine

Saad Nasir: Thrilled to announce that my abstract has been accepted for a poster presentation at ASCO24

Matthew Kurian: Integrating AI into our everyday practice and decision-making

Antoine Yabar: Grateful for this ASCO24 online publication acceptance

Jennifer C. King: Abstracts are due this week, be part of the International Association for the Study of Lung Cancer (IASLC) 50th Anniversary World Conference on Lung Cancer!

Jarushka Naidoo: Phase II trial of Tumor-Infiltrating Lymphocyte (TIL) therapy (Lifileucel) in Advanced Non-Small Cell Lung Cancer post Immunotherapy with or without chemotherapy

Adam Yopp: Sam C. Wang, the epitome of a surgeon-scientist, recently awarded second NIH R01 grant studying gastric cancer

Rochelle Prosser: Giving patients a voice in cancer treatment benefits everyone

Elisa Agostinetto: A pooled analysis exploring tumor intrinsic subtypes in 3 trials on HER2+ EBC

Nicole Grogan Fleege: Being perfect was the way that I would ‘get out’ or ‘make it’

Headlines

03/04/2024

Bishoy Faltas: Thrilled to take on this new role as Chief Research Officer of the Englander Institute for Precision Medicine

Saad Nasir: Thrilled to announce that my abstract has been accepted for a poster presentation at ASCO24

Matthew Kurian: Integrating AI into our everyday practice and decision-making

Antoine Yabar: Grateful for this ASCO24 online publication acceptance

Jennifer C. King: Abstracts are due this week, be part of the International Association for the Study of Lung Cancer (IASLC) 50th Anniversary World Conference on Lung Cancer!

Jarushka Naidoo: Phase II trial of Tumor-Infiltrating Lymphocyte (TIL) therapy (Lifileucel) in Advanced Non-Small Cell Lung Cancer post Immunotherapy with or without chemotherapy

Adam Yopp: Sam C. Wang, the epitome of a surgeon-scientist, recently awarded second NIH R01 grant studying gastric cancer

Rochelle Prosser: Giving patients a voice in cancer treatment benefits everyone

Elisa Agostinetto: A pooled analysis exploring tumor intrinsic subtypes in 3 trials on HER2+ EBC

Nicole Grogan Fleege: Being perfect was the way that I would ‘get out’ or ‘make it’

Headlines

OncoDaily

Oncology

cancer

fight against cancer

Global fight against cancer

cancer care

Breast Cancer

ASCO

Lung cancer

Cancer research

MD Anderson Cancer Center

cancer awareness

NSCLC

ESMO

immunotherapy

cancer treatment

Research

ASCO24

Headlines

colorectal cancer

Childhood Cancer

prostate cancer

AACR

clinical trials

FDA

Dana-Farber Cancer Institute

UICC

American Cancer Society

European Cancer Organisation

NCI

National Cancer Institute

healthcare

SIOP

ASCO25

chemotherapy

Vivek Subbiah

AI

American Society of Clinical Oncology

Paolo Tarantino

IASLC

WHO

Robert Orlowski

multiple myeloma

Memorial Sloan Kettering Cancer Center

Zainab Shinkafi-Bagudu

radiation oncology

Myeloma Paper of the Day

cervical cancer

Myeloma

patient care

European School of Oncology

Sitemap